BACKGROUND: Persistent carriers have a higher risk of Staphylococcus aureus infections than noncarriers but a lower risk of bacteremia-related death. Here, the role played by anti-staphylococcal antibodies was studied. METHODS: Serum samples from 15 persistent carriers and 19 noncarriers were analyzed for immunoglobulin (Ig) G, IgA, and IgM binding to 19 S. aureus antigens, by means of Luminex technology. Nasal secretions and serum samples obtained after 6 months were also analyzed. RESULTS: Median serum IgG levels were significantly higher in persistent carriers than in noncarriers for toxic shock syndrome toxin (TSST)-1 (median fluorescence intensity [MFI] value, 11,554 vs. 4291; P < .001) and staphylococcal enterotoxin (SE) A (742 vs. 218; P < .05); median IgA levels were higher for TSST-1 (P < .01), SEA, and clumping factor (Clf) A and B (P < .05). The in vitro neutralizing capacity of anti-TSST-1 antibodies was correlated with the MFI value (R(2) = 0.93) and was higher in persistent carriers (90.6% vs. 70.6%; P < .05). Antibody levels were stable over time and correlated with levels in nasal secretions (for IgG, R(2) = 0.87; for IgA, R(2) = 0.77). CONCLUSIONS: Antibodies to TSST-1 have a neutralizing capacity, and median levels of antibodies to TSST-1, SEA, ClfA, and ClfB are higher in persistent carriers than in noncarriers. These antibodies might be associated with the differences in the risk and outcome of S. aureus infections between nasal carriers and noncarriers.
BACKGROUND: Persistent carriers have a higher risk of Staphylococcus aureus infections than noncarriers but a lower risk of bacteremia-related death. Here, the role played by anti-staphylococcal antibodies was studied. METHODS: Serum samples from 15 persistent carriers and 19 noncarriers were analyzed for immunoglobulin (Ig) G, IgA, and IgM binding to 19 S. aureus antigens, by means of Luminex technology. Nasal secretions and serum samples obtained after 6 months were also analyzed. RESULTS: Median serum IgG levels were significantly higher in persistent carriers than in noncarriers for toxic shock syndrome toxin (TSST)-1 (median fluorescence intensity [MFI] value, 11,554 vs. 4291; P < .001) and staphylococcal enterotoxin (SE) A (742 vs. 218; P < .05); median IgA levels were higher for TSST-1 (P < .01), SEA, and clumping factor (Clf) A and B (P < .05). The in vitro neutralizing capacity of anti-TSST-1 antibodies was correlated with the MFI value (R(2) = 0.93) and was higher in persistent carriers (90.6% vs. 70.6%; P < .05). Antibody levels were stable over time and correlated with levels in nasal secretions (for IgG, R(2) = 0.87; for IgA, R(2) = 0.77). CONCLUSIONS: Antibodies to TSST-1 have a neutralizing capacity, and median levels of antibodies to TSST-1, SEA, ClfA, and ClfB are higher in persistent carriers than in noncarriers. These antibodies might be associated with the differences in the risk and outcome of S. aureus infections between nasal carriers and noncarriers.
Authors: Nienke W M de Jong; Kasra X Ramyar; Fermin E Guerra; Reindert Nijland; Cindy Fevre; Jovanka M Voyich; Alex J McCarthy; Brandon L Garcia; Kok P M van Kessel; Jos A G van Strijp; Brian V Geisbrecht; Pieter-Jan A Haas Journal: Proc Natl Acad Sci U S A Date: 2017-08-14 Impact factor: 11.205
Authors: Jasper Swierstra; Stephanie Debets; Corné de Vogel; Nicole Lemmens-den Toom; Nelianne Verkaik; Nadjia Ramdani-Bouguessa; Marcel F Jonkman; Jan Maarten van Dijl; Ahmed Fahal; Alex van Belkum; Willem van Wamel Journal: Infect Immun Date: 2014-11-17 Impact factor: 3.441
Authors: Liana C Chan; Siyang Chaili; Scott G Filler; Lloyd S Miller; Norma V Solis; Huiyuan Wang; Colin W Johnson; Hong K Lee; Luis F Diaz; Michael R Yeaman Journal: Infect Immun Date: 2017-01-26 Impact factor: 3.441
Authors: N J Verkaik; H A Boelens; C P de Vogel; M Tavakol; L G M Bode; H A Verbrugh; A van Belkum; W J B van Wamel Journal: Eur J Clin Microbiol Infect Dis Date: 2010-02-26 Impact factor: 3.267
Authors: Elisabeth Israelsson; Damien Chaussabel; Rebecca S B Fischer; Heather C Moore; D Ashley Robinson; Jesse W Dunkle; Heather T Essigmann; Sharron Record; Eric L Brown Journal: Microbes Infect Date: 2020-08-03 Impact factor: 2.700